Altogether, our data suggest the presence of cognitive impairment both in AD (APP/PS1-Sham) and diabetic (Wt-STZ) mice, with a synergistic effect in APP/PS1-STZ mice, supporting a cross-talk between both pathology types that worsens episodic and spatial memory. Here, APP is linked to Alzheimer disease.